BR100 Decreased By (-0.06%)
BR30 Increased By (1.22%)
KSE100 Decreased By (-0.07%)
KSE30 Decreased By (-0.47%)
AGHA 7.69 Decreased By ▼ -0.05 (-0.65%)
BECO 5.24 Decreased By ▼ -0.05 (-0.95%)
BML 60.22 Increased By ▲ 0.21 (0.35%)
BOP 35.28 Decreased By ▼ -1.18 (-3.24%)
CNERGY 13.13 Increased By ▲ 1.19 (9.97%)
CSIL 6.11 Decreased By ▼ -0.06 (-0.97%)
FCCL 57.97 Increased By ▲ 0.61 (1.06%)
FFL 16.42 Decreased By ▼ -0.16 (-0.97%)
FNEL 1.20 No Change ▼ 0.00 (0%)
KEL 7.48 Increased By ▲ 0.16 (2.19%)
KOSM 6.04 Decreased By ▼ -0.01 (-0.17%)
LOTCHEM 27.75 Increased By ▲ 0.61 (2.25%)
MLCF 102.98 Increased By ▲ 0.91 (0.89%)
NBP 206.04 Decreased By ▼ -0.31 (-0.15%)
NCPL 62.24 Decreased By ▼ -0.38 (-0.61%)
NPL 71.29 Decreased By ▼ -0.69 (-0.96%)
OGDC 323.78 Increased By ▲ 4.59 (1.44%)
PACE 11.51 Increased By ▲ 0.13 (1.14%)
PAEL 43.90 Increased By ▲ 0.02 (0.05%)
PIBTL 16.68 Decreased By ▼ -0.16 (-0.95%)
PPL 229.47 Increased By ▲ 7.92 (3.57%)
PRL 70.11 Increased By ▲ 6.36 (9.98%)
PTC 72.15 Decreased By ▼ -0.26 (-0.36%)
SSGC 27.11 Decreased By ▼ -0.17 (-0.62%)
TBL 9.86 No Change ▼ 0.00 (0%)
TELE 8.72 Increased By ▲ 0.10 (1.16%)
TPL 22.62 Increased By ▲ 1.94 (9.38%)
TPLP 15.68 Increased By ▲ 0.70 (4.67%)
TREET 24.21 Increased By ▲ 0.11 (0.46%)
TRG 61.13 Decreased By ▼ -2.16 (-3.41%)
By

The UK’s FTSE 100 started the year on a positive note, underpinned by energy shares on Tuesday, while investors looked ahead to economic data this week and its potential impact on the Bank of England’s interest rate trajectory.

The blue-chip FTSE 100 was up 0.3% by 0814 GMT, touching an over seven-month high, while the midcap index FTSE 250 edged down 0.1%.

Energy shares climbed 0.9% after oil prices jumped 1% on potential Middle East supply disruptions and expectations of an economic stimulus from world’s top crude importer China.

In company news, Marks And Spencer soared 1.7% after Exane BNP Paribas raised the retailer’s stock rating to “outperform” from “neutral”.

UK’s FTSE 100 slips for second straight session as financials drag

Shares of HSBC fell 0.4% as its subsidiary HSBC Continental Europe completed the sale of its retail banking business in France to Crédit Commercial de France.

Drugmaker AstraZeneca slid 0.3% even as its respiratory syncytial virus immunization for infants, developed with Sanofi, got an approval in China.

Manufacturing and services activity and housing prices data will be on investors’ radar through the week to assess the strength of the British economy, which might be in a recession.

Comments

Comments are closed for this article.